These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 23874629)
1. Health disparities from economic burden of diabetes in middle-income countries: evidence from México. Arredondo A; Reyes G PLoS One; 2013; 8(7):e68443. PubMed ID: 23874629 [TBL] [Abstract][Full Text] [Related]
2. Economic consequences of epidemiological changes in diabetes in middle-income countries: the Mexican case. Arredondo A; Zúñiga A Diabetes Care; 2004 Jan; 27(1):104-9. PubMed ID: 14693974 [TBL] [Abstract][Full Text] [Related]
3. [The cost of diabetes in Latin America: evidence from Mexico]. Arredondo A; De Icaza E Value Health; 2011; 14(5 Suppl 1):S85-8. PubMed ID: 21839907 [TBL] [Abstract][Full Text] [Related]
4. Costs and epidemiological changes of chronic diseases: implications and challenges for health systems. Arredondo A; Aviles R PLoS One; 2015; 10(3):e0118611. PubMed ID: 25781625 [TBL] [Abstract][Full Text] [Related]
5. Trends and challenges in diabetes for middle-income countries: Evidence from Mexico. Arredondo A; Orozco E; Duarte MB; Cuadra M; Recaman AL; Azar A Glob Public Health; 2019 Feb; 14(2):227-240. PubMed ID: 30068257 [TBL] [Abstract][Full Text] [Related]
6. Challenges on the epidemiological and economic burden of diabetes and hypertension in Mexico. Arredondo A; Orozco E; Alcalde-Rabanal J; Navarro J; Azar A Rev Saude Publica; 2018; 52():23. PubMed ID: 29489993 [TBL] [Abstract][Full Text] [Related]
7. [Financial requirements for health services demands for diabetes and hypertension in Mexico: 2001-2003]. Arredondo A Rev Invest Clin; 2001; 53(5):422-9. PubMed ID: 11795108 [TBL] [Abstract][Full Text] [Related]
8. Health care costs and financial consequences of epidemiological changes in chronic diseases in Latin America: evidence from Mexico. Arredondo A; Zúñiga A; Parada I Public Health; 2005 Aug; 119(8):711-20. PubMed ID: 15885723 [TBL] [Abstract][Full Text] [Related]
9. Challenges of the epidemiological and economic burdens associated with hypertension in middle income countries: evidence from Mexico. Arredondo A; Cuadra SM; Duarte MB BMC Public Health; 2015 Nov; 15():1106. PubMed ID: 26546356 [TBL] [Abstract][Full Text] [Related]
10. Diabetes, a global public health challenge with a high epidemiological and economic burden on health systems in Latin America. Arredondo A; Azar A; Recamán AL Glob Public Health; 2018 Jul; 13(7):780-787. PubMed ID: 28447537 [TBL] [Abstract][Full Text] [Related]
11. Epidemiologic changes and economic burden of hypertension in Latin America: evidence from Mexico. Arredondo A; Zúñiga A Am J Hypertens; 2006 Jun; 19(6):553-9. PubMed ID: 16733225 [TBL] [Abstract][Full Text] [Related]
12. Epidemiological and financial indicators of hypertension in older adults in Mexico: challenges for health planning and management in Latin America. Arredondo A; Duarte MB; Cuadra SM Int J Health Plann Manage; 2017 Apr; 32(2):e121-e136. PubMed ID: 27238949 [TBL] [Abstract][Full Text] [Related]
13. Challenges and dilemmas on universal coverage for non-communicable diseases in middle-income countries: evidence and lessons from Mexico. Arredondo A; Azar A; Recaman AL Global Health; 2018 Aug; 14(1):89. PubMed ID: 30143010 [TBL] [Abstract][Full Text] [Related]